Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of vaginal versus oral bromocriptine for hyperprolactinemia in infertile women
PACTR202105631565416Recruiting
- Sponsor
- Irshad Asma
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bromocriptine in hyperprolactinemia (2 arms), sponsored by Irshad Asma. Primary endpoints: Percentage fall in serum prolactin levels, Unit drop in prolactin levels and 1 more. Started Nov 2020; status: recruiting.
02
Drugs
bromocriptine
03
Conditions
hyperprolactinemia
Beyond the preview
Go deeper on PACTR202105631565416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202105631565416.